Fluconazole
- TRADE NAMES: Biozolene; Diflucan (Pfizer); Flucazol; Flukezol; Fluzone; Fungata; Triflucan
- INDICATIONS: Candidiasis
- CLASS: Antifungal / antimycotic, Antifungal; triazole, Antimicrobial, CYP3A4 inhibitor
- HALF-LIFE: 25–30 hours
Alprazolam, Amphotericin B, Anisindione, Anticoagulants, Atorvastatin, Avanafil, Betamethasone, Bosentan, Celecoxib, Citalopram, Clobazam, Clopidogrel, Deflazacort, Dicumarol, Eluxadoline, Eplerenone, Erythromycin, Flibanserin, Irbesartan, Ivacaftor, Lesinurad, Methadone, Midazolam, Mifepristone, Naldemedine, Neratinib, Nevirapine, Olaparib, Ospemifene, Pantoprazole, Phenobarbital, Phenytoin, Pimecrolimus, Propranolol, Quetiapine, Ramelteon, Rifapentine, Rilpivirine, Ruxolitinib, Simeprevir, Sonidegib, Sulfonylureas, Temsirolimus, Terbinafine, Tezacaftor/Ivacaftor, Tipranavir, Tofacitinib, Trabectedin, Triamcinolone, Venetoclax, Vinblastine, Vincristine, Warfarin, Zidovudine
PREGNANCY CATEGORY: D
fluconazole is pregnancy category C for vaginal candidiasis
Please login to see the rest of this drug profile
Page last updated 03/16/2022
Symbol key
Incidence 
- <1%
- 1-5%
- 5-10%
- 10-15%
- 15-20%
- 20-30%
- >30%
Seriousness
- Hospitalization possible
- Life threatening
- Fatal
Warnings in other populations
- Breast feeding
- Geriatric
- Pediatric
